week in cancer news

Study finds a connection between bacteria and fast-growing prostate cancer, and researchers measure underrepresentation of Black patients in clinical trials.

by Kevin McLaughlin

Trial of ‘practice-changing’ immunotherapy yields positive results for lung cancer patients, and CAR T-cell therapy shows effectiveness in targeting certain solid tumors.

by Thomas Celona

CAR T-cell therapy approved for relapsed large B-cell lymphoma, and screening catches lung cancer earlier, although disparities persist.

by Kevin McLaughlin

Chemo brain may provide clues for long-haul COVID-19, and researchers analyze relationship between obesity and cancer.

by Marci A. Landsmann

FDA approves combination immunotherapy for treating melanoma, and screening tool improves pancreatic cancer detection.

by Kevin McLaughlin

Metastatic prostate cancer incidence rose after recommendation against routine screening, and FDA approves first PARP inhibitor for early-stage breast cancer for people with inherited BRCA mutations.

by Eric Fitzsimmons

FDA approves neoadjuvant immunotherapy treatment for lung cancer, and radiation might not be needed for low-risk thyroid cancer.

by Kevin McLaughlin

Study finds lower rates of screening-related breast cancer overdiagnosis and children with cancer in Ukraine continue treatment in hospital’s basement.

by Marci A. Landsmann

Screening program reduces disparities in colorectal cancer, and seeing the challenges of getting cancer care through one woman’s story.

by Eric Fitzsimmons

Aspirin is ineffective in preventing breast cancer recurrence, and immunotherapy holds promise for some patients with advanced anal cancer.

by Kevin McLaughlin